Study identifier:D9422C00001
ClinicalTrials.gov identifier:NCT01444092
EudraCT identifier:N/A
CTIS identifier:N/A
A Multicenter, Open label, Non-comparative Study to Evaluate the Safety of Entocort EC for the Treatment of Crohn's Disease in Paediatric Subjects Aged 5 to 17 Years, Inclusive
Crohn's disease
Phase 3
No
Entocort
All
123
Interventional
5 Years - 17 Years
Allocation: N/A
Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Verified 01 Jun 2016 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|---|
Experimental: Entocort Study Medication | Drug: Entocort Entocort capsules, oral |